Ginsburg E, Vonderhaar B K
Cancer Lett. 1985 Sep 15;28(2):143-50. doi: 10.1016/0304-3835(85)90069-2.
Growth of the human epidermoid carcinoma cell line A431 in vitro is stimulated by low concentrations of epidermal growth factor (EGF; 0.1-10 pM) and inhibited by high concentrations (0.1-10 nM). This cell also grows as a solid tumor in female athymic mice. Sustained high levels of EGF in vivo can be achieved by the administration of testosterone to female mice via a cholesterol-based pellet inserted subcutaneously. This chronic elevation of EGF levels (serum concentration = 90 ng/ml), however, does not affect growth of the tumor. In contrast, low levels of the growth factor (0.5 micrograms/g body wt by injection 5 times/week; serum concentration = 8.25 ng/ml) stimulate growth of the tumor. These data suggest that the mechanism(s) involved in the inhibition of A431 cell growth by EGF in vitro does not function in vivo and the physiologically significant effect of EGF in vivo is growth promotion.
低浓度的表皮生长因子(EGF;0.1 - 10皮摩尔)可刺激人表皮样癌细胞系A431在体外生长,而高浓度(0.1 - 10纳摩尔)则会抑制其生长。该细胞在雌性无胸腺小鼠体内也会形成实体瘤。通过皮下植入基于胆固醇的药丸给雌性小鼠注射睾酮,可使体内EGF持续处于高水平。然而,EGF水平的这种慢性升高(血清浓度 = 90纳克/毫升)并不影响肿瘤的生长。相反,低水平的生长因子(每周注射5次,每次0.5微克/克体重;血清浓度 = 8.25纳克/毫升)会刺激肿瘤生长。这些数据表明,EGF在体外抑制A431细胞生长的机制在体内不起作用,且EGF在体内的生理显著作用是促进生长。